[1]陈文福.噻托溴铵治疗稳定期慢性阻塞性肺疾病的临床疗效分析[J].医学信息,2018,31(02):124-125.[doi:10.3969/j.issn.1006-1959.2018.02.045]
　CHEN Wen-fu.Clinical Analysis of Tiotropium Bromide in the Treatment of Stable Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(02):124-125.[doi:10.3969/j.issn.1006-1959.2018.02.045]
点击复制

噻托溴铵治疗稳定期慢性阻塞性肺疾病的临床疗效分析()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
31卷
期数:
2018年02期
页码:
124-125
栏目:
药物与临床
出版日期:
2018-01-15

文章信息/Info

Title:
Clinical Analysis of Tiotropium Bromide in the Treatment of Stable Chronic Obstructive Pulmonary Disease
文章编号:
1006-1959（2018）02-0124-02
作者:
陈文福
中国人民解放军第三〇三医院呼吸科，广西 南宁 530021
Author(s):
CHEN Wen-fu
Department of Respiratory,No.303 Hospital of the Chinese People's Liberation Army,Nanning 530021,Guangxi,China
关键词:
慢性阻塞性肺疾病; 稳定期; 噻托溴铵
Keywords:
Key words：Chronic obstructive pulmonary disease; Stable phase; Tiotropium bromide
分类号:
R563.9
DOI:
10.3969/j.issn.1006-1959.2018.02.045
文献标志码:
A
摘要:
目的 分析稳定期慢性阻塞性肺疾病应用噻托溴铵治疗的临床效果，观察患者各项指标恢复情况。方法 采用数字随机法将2016年1月~2017年5月收治的慢性阻塞性疾病稳定期患者106例分成两组，各53例，对照组采用常规治疗，观察组患者采用噻托溴铵治疗，比较两组的临床效果及患者10 min步行距离、住院时间。结果 观察组治疗总有效率94.34%，高于对照组的83.19%，差异有统计学意义（P＜0.05）；观察组患者住院时间为（6.15±1.19）d，少于对照组的（11.19±1.07）d，差异有统计学意义（P＜0.05）。结论 稳定期慢性阻塞性肺疾病应用噻托溴铵治疗的临床效果较好，患者的各项恢复情况明显，有效的缩短住院时间，减轻患者的痛苦及经济负担，值得临床推广。
Abstract:
Abstract：Objective To analyze the clinical effect of tiotropium in the treatment of chronic obstructive pulmonary disease(COPD)in stable phase and observe the recovery of various indexes in patients.Methods A total of 106 stable patients with chronic obstructive disease admitted from January 2016 to May 2017 were divided into two groups(n=53)by digital randomization method.Patients in the observation group were treated with tiotropium,patients in the observation group were treated with tiotropium.The clinical effects and the walking distance and hospital stay of 10 min were compared between the two groups.Results The total effective rate of observation group was 94.34%,which was higher than that of control group 83.19%,the difference was statistically significant(P<0.05);The length of hospital stay in the observation group was(6.15±1.19)d,which was less than that in the control group (11.19±1.07)d.The difference was statistically significant(P<0.05).Conclusion The clinical efficacy of tiotropium in patients with stable chronic obstructive pulmonary disease is better,and the recovery of patients is obvious,effectively shortening the hospital stay and alleviating the suffering and financial burden of patients,which is worthy of clinical promotion.

参考文献/References:

[1]邓创豪,邓琪武,梁惠贤,等.噻托溴铵与沙美特罗氟替卡松序贯治疗稳定期慢性阻塞性肺疾病的临床分析[J].中国实用医药,2017,12(21):11-13.
[2]边喜明.噻托溴铵治疗稳定期慢性阻塞性肺疾病的临床分析[J].临床医药文献电子杂志,2016,3(37):7445-7446.
[3]张永庆,苗毅,尚立群,等.布地奈德福莫特罗联合噻托溴铵治疗中重度慢阻肺稳定期疗效观察[J].陕西医学杂志,2016,45(04):494-495.
[4]罗红.噻托溴铵联合家庭氧疗治疗稳定期重度慢性阻塞性肺疾病临床分析[J].实用医院临床杂志,2014,11(04):203-205.
[5]邓创豪,邓琪武,梁惠贤,张丹婷,康奕飞,薛瑞君,刘付亮.噻托溴铵与沙美特罗氟替卡松序贯治疗稳定期慢性阻塞性肺疾病的临床分析[J].中国实用医药,2017,12(21):11-13.
[6]付爽,王虹.噻托溴铵与沙美特罗氟替卡松联合治疗慢性阻塞性肺疾病的临床疗效分析[J].中国冶金工业医学杂志,2017,34(03):307-308.
[7]吴晓虞,何六涛,陈华春.噻托溴铵联合舒利迭治疗慢性阻塞性肺疾病稳定期患者的临床疗效研究[J].中国生化药物杂志,2017,37(05):229-231.
[8]王万征,安军.噻托溴铵对稳定期慢性阻塞性肺疾病患者临床疗效及相关血清标志物水平的影响[J].中国慢性病预防与控制,2017,25(05):358-360.

相似文献/References:

[1]钟雪梅,李 黎,米热班·热夏提,等.α1-抗胰蛋白酶与维吾尔族慢性阻塞性肺疾病的相关性分析[J].医学信息,2018,31(02):67.[doi:10.3969/j.issn.1006-1959.2018.02.023]
　ZHONG Xue-mei,LI Li,Mirban·rixat,et al.Correlation Analysis of α1-antitrypsin and Uygur Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(02):67.[doi:10.3969/j.issn.1006-1959.2018.02.023]
[2]吴仲东.无创机械通气用于COPD合并呼吸衰竭的疗效分析[J].医学信息,2018,31(04):106.[doi:10.3969/j.issn.1006-1959.2018.04.036]
　WU Zhong-dong.Clinical Analysis of Noninvasive Mechanical Ventilation in Patients with COPD Complicated with Respiratory Failure[J].Journal of Medical Information,2018,31(02):106.[doi:10.3969/j.issn.1006-1959.2018.04.036]
[3]龙有珠.氨茶碱联合呼吸功能训练治疗慢性阻塞性肺疾病的疗效分析[J].医学信息,2018,31(04):127.[doi:10.3969/j.issn.1006-1959.2018.04.045]
　LONG You-zhu.Effect of Aminophylline Combined with Respiratory Function Training on Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(02):127.[doi:10.3969/j.issn.1006-1959.2018.04.045]
[4]皮鑫鑫,邓 革.临床药师对1例院内感染患者的病例分析[J].医学信息,2018,31(04):188.[doi:10.3969/j.issn.1006-1959.2018.04.072]
[5]罗 倩.COPD加重期患者肺功能、血气指标及 炎症指标的变化分析[J].医学信息,2018,31(09):114.[doi:10.3969/j.issn.1006-1959.2018.09.034]
　LUO Qian.Changes of Pulmonary Function,Blood Gas and Inflammation in Patients with COPD Exacerbation[J].Journal of Medical Information,2018,31(02):114.[doi:10.3969/j.issn.1006-1959.2018.09.034]
[6]赵志国.有创-无创序贯通气疗法治疗慢性阻塞性肺疾病 引发的严重呼吸衰竭的临床研究[J].医学信息,2018,31(11):110.[doi:10.3969/j.issn.1006-1959.2018.11.034]
　ZHAO Zhi-guo.Clinical Study of Invasive Non-invasive Sequential Ventilation in Treatment of Severe Respiratory Failure Caused by Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(02):110.[doi:10.3969/j.issn.1006-1959.2018.11.034]
[7]金彦青.NPPV治疗慢性阻塞性肺疾病合并 重症呼吸衰竭的临床疗效观察[J].医学信息,2018,31(14):113.[doi:10.3969/j.issn.1006-1959.2018.14.033]
　JIN Yan-qing.Clinical Efficacy of NPPV in the Treatment of Chronic Obstructive Pulmonary Disease with Severe Respiratory Failure[J].Journal of Medical Information,2018,31(02):113.[doi:10.3969/j.issn.1006-1959.2018.14.033]
[8]何冬兰,李 文.NLR、PLR在慢性阻塞性肺疾病进展、预后中的相关研究[J].医学信息,2022,35(11):25.[doi:10.3969/j.issn.1006-1959.2022.11.008]
　HE Dong-lan,LI Wen.Study on Correlation Between NLR and PLR in the Progression and Prognosis of Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2022,35(02):25.[doi:10.3969/j.issn.1006-1959.2022.11.008]
[9]张 林,白 俐.扶正化瘀胶囊对慢性阻塞性肺疾病患者炎性因子及 MMP-9、TIMP-1的影响[J].医学信息,2018,31(14):152.[doi:10.3969/j.issn.1006-1959.2018.14.047]
　ZHANG Lin,BAI Li.Effect of Fuzheng Huayu Capsule on Inflammatory Factors,MMP-9 and TIMP-1 in Patients with Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(02):152.[doi:10.3969/j.issn.1006-1959.2018.14.047]
[10]张善芳,汤 杰.穴位注射联合沙美特罗替卡松粉吸入剂治疗 慢性阻塞性肺疾病稳定期的临床疗效观察[J].医学信息,2018,31(16):131.[doi:10.3969/j.issn.1006-1959.2018.16.041]
　ZHANG Shan-fang,TANG Jie.Clinical Observation of Acupoint Injection Combined with Salmeterol and Fluticasone Powder Inhalation in the Treatment of Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2018,31(02):131.[doi:10.3969/j.issn.1006-1959.2018.16.041]
[11]史 静.家庭护理干预对提高稳定期慢性阻塞性肺疾病患者 生活质量的研究[J].医学信息,2019,32(15):182.[doi:10.3969/j.issn.1006-1959.2019.15.062]
　SHI Jing.Study on the Improvement of Quality of Life in Patients with Stable Chronic Obstructive Pulmonary Disease by Home Nursing Intervention[J].Journal of Medical Information,2019,32(02):182.[doi:10.3969/j.issn.1006-1959.2019.15.062]
[12]卞 蕊.健康信念模式对慢性阻塞性肺疾病稳定期患者的护理效果[J].医学信息,2020,33(21):176.[doi:10.3969/j.issn.1006-1959.2020.21.056]
　BIAN Rui.The Effect of Health Belief Model on Patients with Stable Chronic Obstructive Pulmonary Disease[J].Journal of Medical Information,2020,33(02):176.[doi:10.3969/j.issn.1006-1959.2020.21.056]

更新日期/Last Update: 2018-02-15